ELIXIR MD, Inc. Expands Offerings in Mexico with New Partnership
ELIXIR MD, Inc., recognized for its innovation in advanced aesthetic non-invasive medical technology, is making significant strides by entering the Mexican market through a strategic partnership. This collaboration involves esteemed plastic surgeons, Dr. Leonardo Moreno-Tevizo and Dr. Andrés Bello Margalef, who will help implement the cutting-edge ELIXIR MD™ device for enhanced patient care.
Commitment to Patient-Centric Solutions
According to Ewan Mohammed, CEO of ELIXIR MD, Inc., the ELIXIR MD™ device has been designed to meet the needs of plastic surgeons, providing patients with the ability to recover faster and enjoy improved outcomes. This commitment to patient-centric solutions is what drives the expansion into Mexico, marking it as the 17th country for the company.
Feedback from Surgeons on the ELIXIR MD™ Device
Dr. Leonardo Moreno-Tevizo expressed enthusiasm for bringing the ELIXIR MD™ technology and protocols to his patients, highlighting the device’s ability to facilitate more precise and comfortable treatments. Dr. Andrés Bello Margalef also praised the technology, noting its potential to reduce recovery times significantly, establishing a new standard in the field.
Insights into the Mexican Aesthetic Medicine Market
Mexico stands as a major player in the global aesthetic medicine landscape, ranking third in terms of the volume of plastic surgery procedures performed worldwide, surpassed only by the United States and Brazil. The market is flourishing, supported by a blend of local and international clients who are increasingly drawn by the efficacy and safety of treatments offered.
Growth Projections for Aesthetic Procedures in Mexico
The demand for aesthetic procedures in Mexico has witnessed a remarkable hike, spurred on by the surge in medical tourism and the growing middle-class population eager to invest in their appearance. The country's aesthetic medicine market was valued at approximately $2.6 billion in 2024 and is projected to skyrocket to over $6.1 billion by 2030, reflecting a robust annual growth rate of about 15.6%.
About ELIXIR MD, Inc.
Headquartered in Irvine, California, ELIXIR MD, Inc. is dedicated to revolutionizing patient recovery following plastic surgery, aiming for significant improvements in outcomes by 2030. With a presence in 17 countries, including the United States, the company has delivered over 22,000 hours of treatment specifically designed for plastic surgery patients. The firm's diverse portfolio includes the FDA-cleared ELIXIR MD™ and EVA 3D™ devices, rooted in the "360 Aesthetic Recovery Model" that integrates comprehensive treatment protocols from initial assessments to post-surgical care.
Frequently Asked Questions
What is the significance of ELIXIR MD's expansion into Mexico?
This expansion allows ELIXIR MD to provide state-of-the-art aesthetic solutions increased access to innovative treatments for Mexican patients.
Who are the key partners in this expansion?
Dr. Leonardo Moreno-Tevizo and Dr. Andrés Bello Margalef are the leading plastic surgeons collaborating with ELIXIR MD for this initiative.
What is the projected growth for aesthetic medicine in Mexico?
Mexico's aesthetic market is expected to grow from $2.6 billion to over $6.1 billion by 2030, indicating strong demand for cosmetic procedures.
How does ELIXIR MD™ improve patient recovery?
ELIXIR MD™ is designed to facilitate faster recovery and better outcomes, providing patients a comfortable and efficient healing process.
Where can I find more information about ELIXIR MD, Inc.?
Further details about ELIXIR MD and its offerings can be found on their official website.
